Published in Emerg Infect Dis on March 28, 2001
Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis (2004) 1.25
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill (2013) 2.63
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl J Med (2001) 2.38
New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill (2010) 2.09
Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol Lett (1999) 1.93
Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2003) 1.91
Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J Infect Dis (1986) 1.84
Infections with the unusual human pathogens Agrobacterium species and Ochrobactrum anthropi. Clin Infect Dis (1994) 1.83
Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect (1997) 1.79
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother (2000) 1.76
Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration. Infection (1995) 1.61
Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect (2007) 1.61
Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis (1996) 1.59
National hand hygiene campaigns in Europe, 2000-2009. Euro Surveill (2009) 1.58
Emergence and characterization of community-associated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol (2008) 1.51
Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med (1999) 1.48
In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection (2002) 1.48
Nosocomial pneumonia in an intensive care unit in a Danish university hospital: incidence, mortality and etiology. Scand J Infect Dis (1992) 1.46
Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicrob Agents Chemother (1995) 1.37
Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med (1999) 1.36
Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother (2002) 1.35
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents (2000) 1.33
[Treatment of upper respiratory tract infections]. Ugeskr Laeger (2000) 1.31
Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol (1999) 1.31
In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother (2001) 1.29
Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. J Antimicrob Chemother (2005) 1.28
Bacteremic Staphylococcus aureus spondylitis. Arch Intern Med (1998) 1.28
Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med (1986) 1.24
Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother (1997) 1.21
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother (1998) 1.19
European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics. Euro Surveill (2014) 1.18
Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001-2007. Euro Surveill (2009) 1.17
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Euro Surveill (2007) 1.16
Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun (2010) 1.14
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J Antimicrob Chemother (2003) 1.13
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother (2005) 1.09
Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents (2007) 1.08
Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother (2001) 1.07
Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis (2001) 1.07
Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrob Agents Chemother (1997) 1.06
[Daily single-dose aminoglycoside administration. Therapeutic and economic benefits]. Ugeskr Laeger (1993) 1.06
European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill (2009) 1.05
Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis (2011) 1.03
Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun (1999) 1.00
Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage. Thorax (1992) 0.99
Changing pattern of bone and joint infections due to Staphylococcus aureus: study of cases of bacteremia in Denmark, 1959-1988. Rev Infect Dis (1991) 0.98
Microbial status and product labelling of 58 original tattoo inks. J Eur Acad Dermatol Venereol (2011) 0.98
First detection of plasmid-mediated quinolone resistance (qnrA and qnrS) in Escherichia coli strains isolated from humans in Scandinavia. J Antimicrob Chemother (2007) 0.97
Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother (2001) 0.97
Antimicrobial resistance in Salmonella enterica subsp. enterica serovar typhimurium from humans and production animals. J Antimicrob Chemother (1997) 0.96
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. Antimicrob Agents Chemother (1998) 0.96
Antibiotic treatment insufficient for established septic arthritis. Staphylococcus aureus experiments in rabbits. Acta Orthop Scand (1989) 0.96
Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med (1997) 0.95
The pneumococcus and the mouse protection test: importance of the lag phase in vivo. Chemotherapy (1983) 0.95
Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits. Infect Immun (2000) 0.92
Antibiotic usage in an intensive care unit in a Danish university hospital. J Antimicrob Chemother (1993) 0.91
Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin Microbiol Infect (2007) 0.91
Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection. Antimicrob Agents Chemother (1994) 0.89
Effect of urine concentration versus tissue concentration of ampicillin and mecillinam on bacterial adherence in the rat bladder. Invest Urol (1981) 0.89
Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model. J Antimicrob Chemother (1997) 0.89
Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model. Antimicrob Agents Chemother (2003) 0.89
Staphylococcus aureus meningitis. A review of 104 nationwide, consecutive cases. Arch Intern Med (1993) 0.88
The pneumococcus and the mouse-protection test: correlation of in vitro and in vivo activity for beta-lactam antibiotics, vancomycin, erythromycin and gentamicin. Acta Pathol Microbiol Immunol Scand B (1987) 0.88
Prophylactic antibiotics in transurethral prostatectomy. J Urol (1981) 0.87
Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009. Euro Surveill (2009) 0.87
Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol (2000) 0.87
Collagen with gentamicin for prophylaxis of postoperative infection. Staphylococcus aureus osteomyelitis studied in rabbits. Acta Orthop Scand (1995) 0.87
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints. Clin Microbiol Infect (2007) 0.86
Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model. J Antimicrob Chemother (1998) 0.86
Antibiotic prophylaxis in pulmonary surgery: a double-blind study of penicillin versus placebo. Ann Surg (1982) 0.85
Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungals. Med Mycol (2008) 0.84
Experimental pneumococcus infection in mice: correlation of bactericidal activity in vitro with the effect in vivo for gentamicin, netilmicin and tobramycin. Acta Pathol Microbiol Immunol Scand B (1987) 0.84
Methicillin-resistant Staphylococcus aureus: risk factors associated with community-onset infections in Denmark. Clin Microbiol Infect (2008) 0.84
Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole. Clin Microbiol Infect (2004) 0.83
Hand hygiene practices in healthcare: measure and improve. Euro Surveill (2012) 0.83
Corynebacterium xerosis as a cause of community-acquired endocarditis. Eur J Clin Microbiol Infect Dis (1990) 0.83
Staphylococcus aureus endocarditis in Danish intravenous drug users: high proportion of left-sided endocarditis. Scand J Infect Dis (1995) 0.83
Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis (2006) 0.82
[Demonstration of bacteriuria in elderly hospitalized patients. Comparison between leukocyte and nitrite strips and culture]. Ugeskr Laeger (1992) 0.82
[Fight against microorganisms--an international concern]. Ugeskr Laeger (1996) 0.82
In-vitro activity of methicillin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1985) 0.82
Escherichia coli clonal group A causing bacteraemia of urinary tract origin. Clin Microbiol Infect (2012) 0.81
Increasing multidrug resistance and limited treatment options: situation and initiatives in Europe. Euro Surveill (2008) 0.81
Aminoglycoside resistance among Danish blood culture isolates of coagulase-negative staphylococci. APMIS (1996) 0.81
Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo-controlled study. J Antimicrob Chemother (1986) 0.80
In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities. APMIS (1996) 0.80
A double-blind, randomized, controlled multicentre study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of age. BJU Int (1999) 0.80
Reducing the use of antimicrobial agents in animals and man. J Med Microbiol (2000) 0.80
Synergy between a non-neuroleptic thioxanthene stereo-isomer and penicillin in vivo. APMIS (1988) 0.79
Staphylococcus aureus bacteremia: a 14-year nationwide study in hematological patients with malignant disease or agranulocytosis. Scand J Infect Dis (1995) 0.79
Neonatal colonization with Staphylococcus aureus is not associated with development of atopic dermatitis. Br J Dermatol (2009) 0.79
Mechanism of aminoglycoside resistance in Danish Staphylococcus aureus strains during the years 1979-1987. APMIS (1991) 0.79
Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis. Acta Med Scand (1987) 0.79
[Vibrio vulnificus infections in Denmark during the summer of 1994]. Ugeskr Laeger (1996) 0.79
Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used. APMIS (1996) 0.79
A study of 47 bacteremic Staphylococcus aureus endocarditis cases: 23 with native valves treated surgically and 24 with prosthetic valves. Scand Cardiovasc J (1997) 0.79
The antibacterial activity of a siderophore. 1. In vitro activity of deferoxamine alone and in combination with ascorbic acid on Staphylococcus aureus. APMIS (1989) 0.79